Loading…

Swiss medical technology company Ypsomed announced a long-term supply deal with Novo Nordisk for autoinjectors, supporting Novo Nordisk's weight-loss drug business.
“Swiss medical technology company Ypsomed announced on Wednesday a long-term supply deal with Novo Nordisk for autoinjectors.”reuters.com
Summarized from public sources; check the original articles before acting on it.